ID3 endowment and TGFBR2 deletion enhance iPSC-derived CAR macrophage immunotherapy for hepatocellular carcinoma
Cell Stem Cell · 2026-11
DOI: 10.1016/j.stem.2026.10.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Stem Cell, 2026-11. Verfasst von Chao Tang und 24 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Soochow University, Institutes of Biology and Medical Sciences, Suzhou Medical College of Soochow University, Biomed…. Die Arbeit nennt 68 Literaturangaben. Gefördert von: Jiangsu Province Natural Science Foundation, Soochow University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Affiliated Hospital of Soochow University, Institutes of Biology and Medical Sciences, Suzhou Medical College of Soochow University, Biomedical Basic Research Center of Jiangsu, Soochow University, Suzhou 2151…
- Department of Clinical Laboratory, Wenzhou People's Hospital, Wenzhou 325000, China.
- Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
- CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China; Beijing Key Laboratory of Molecular Imaging, Beijing 100190, China.
- Key Laboratory of Big Data-Based Precision Medicine (Beihang University), Ministry of Industry and Information Technology of China, Beijing 100191, China.
- Division of Gastroenterology and Hepatology, Department of Medicine, Mass General Brigham, Boston, MA 02114, USA.
Förderung
- Jiangsu Province Natural Science Foundation
- Soochow University
- National Natural Science Foundation of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Tang, C., Tong, Y., Han, P., Zhao, J., Wang, X., Song, H., Wang, M., Liu, X., Zhang, Q., Zhu, Q., Qiang, E., Wang, W., Chen, N., Mo, T., Cao, Z., Wei, Z., An, Y., Hui, H., T Chung, R., …, & Shao, T. (2026). ID3 endowment and TGFBR2 deletion enhance iPSC-derived CAR macrophage immunotherapy for hepatocellular carcinoma. Cell Stem Cell. https://doi.org/10.1016/j.stem.2026.10.015
Vancouver
Tang C, Tong Y, Han P, Zhao J, Wang X, Song H, et al. ID3 endowment and TGFBR2 deletion enhance iPSC-derived CAR macrophage immunotherapy for hepatocellular carcinoma. Cell Stem Cell. 2026. doi:10.1016/j.stem.2026.10.015
BibTeX
@article{Tang2026,
author = {Tang, Chao and Tong, Yu and Han, Pengzhe and Zhao, Jing and Wang, Xiaoyi and Song, Huanhuan and Wang, Mengqi and Liu, Xueqin and Zhang, Qianqian and Zhu, Qian and Qiang, Enfei and Wang, Wenting and Chen, Nannan and Mo, Tong and Cao, Zhengnan and Wei, Zechen and An, Yu and Hui, Hui and T Chung, Raymond and Feng, Xin and Zhao, Weifeng and Gao, Mingyuan and Xiong, Sidong and Tian, Jie and Shao, Tuo},
title = {ID3 endowment and TGFBR2 deletion enhance iPSC-derived CAR macrophage immunotherapy for hepatocellular carcinoma},
journal = {Cell Stem Cell},
year = {2026},
doi = {10.1016/j.stem.2026.10.015}
}
EUVIMED